doi: 10.1176/ajp.141.1.20.
Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents
- PMID: 6140865
- DOI: 10.1176/ajp.141.1.20
Item in Clipboard
Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents
Am J Psychiatry.
1984 Jan.
Abstract
Of 41 children, adolescents, and young adults who were withdrawn from chronic neuroleptic treatment, 18 developed tardive dyskinesia, withdrawal dyskinesia, nondyskinetic withdrawal symptoms, or transient behavior deterioration. Development of neuroleptic-related problems seemed to be associated with cumulative neuroleptic dose and possibly with the sex of the subject. Only 12 of the 41 subjects required resumption of neuroleptic treatment after a prolonged trial withdrawal period.
Similar articles
-
Tardive dyskinesia in young mentally retarded individuals.Arch Gen Psychiatry. 1986 Apr;43(4):335-40. doi: 10.1001/archpsyc.1986.01800040045007. Arch Gen Psychiatry. 1986. PMID: 2869741
-
Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients.Am J Psychiatry. 1991 Oct;148(10):1322-8. doi: 10.1176/ajp.148.10.1322. Am J Psychiatry. 1991. PMID: 1680296
-
Intermittent neuroleptic therapy and tardive dyskinesia: a literature review.Hosp Community Psychiatry. 1984 Dec;35(12):1215-9. doi: 10.1176/ps.35.12.1215. Hosp Community Psychiatry. 1984. PMID: 6150891
-
The treatment of tardive dyskinesia.Schweiz Arch Neurol Psychiatr (1985). 1996;147(1):13-8. Schweiz Arch Neurol Psychiatr (1985). 1996. PMID: 8685689 Review.
-
Tardive dyskinesia and other drug-induced movement disorders among handicapped children and youth.Appl Res Ment Retard. 1980;1(1-2):55-69. doi: 10.1016/0270-3092(80)90016-8. Appl Res Ment Retard. 1980. PMID: 6121532 Review. No abstract available.
Cited by
-
Loxapine add-on for adolescents and adults with autism spectrum disorders and irritability.J Child Adolesc Psychopharmacol. 2015 Mar;25(2):150-9. doi: 10.1089/cap.2014.0003. J Child Adolesc Psychopharmacol. 2015. PMID: 25782098 Free PMC article. Clinical Trial.
-
Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes.Drug Saf. 2007;30(3):247-64. doi: 10.2165/00002018-200730030-00006. Drug Saf. 2007. PMID: 17343431 Review.
-
Tardive dyskinesia and pregnancy and delivery complications.Child Psychiatry Hum Dev. 1996 Spring;26(3):151-7. doi: 10.1007/BF02353356. Child Psychiatry Hum Dev. 1996. PMID: 8819877
-
Pharmacological treatment of psychiatric disorders in children and adolescents: focus on guidelines for the primary care practitioner.Drugs. 1996 May;51(5):750-9. doi: 10.2165/00003495-199651050-00004. Drugs. 1996. PMID: 8861545 Review.
-
Typical neuroleptics in child and adolescent psychiatry.Eur Child Adolesc Psychiatry. 2000;9 Suppl 1:I2-8. doi: 10.1007/s007870070014. Eur Child Adolesc Psychiatry. 2000. PMID: 11140776 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
